Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Assets (2016 - 2025)

Veracyte's Current Assets history spans 14 years, with the latest figure at $449.2 million for Q3 2025.

  • For Q3 2025, Current Assets rose 25.88% year-over-year to $449.2 million; the TTM value through Sep 2025 reached $449.2 million, up 25.88%, while the annual FY2024 figure was $372.3 million, 30.34% up from the prior year.
  • Current Assets for Q3 2025 was $449.2 million at Veracyte, up from $414.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $449.2 million in Q3 2025 and bottomed at $229.3 million in Q3 2021.
  • The 5-year median for Current Assets is $285.6 million (2023), against an average of $306.4 million.
  • The largest YoY upside for Current Assets was 115.04% in 2021 against a maximum downside of 38.08% in 2021.
  • A 5-year view of Current Assets shows it stood at $243.1 million in 2021, then rose by 2.28% to $248.6 million in 2022, then increased by 14.88% to $285.6 million in 2023, then soared by 30.34% to $372.3 million in 2024, then rose by 20.67% to $449.2 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Current Assets are $449.2 million (Q3 2025), $414.7 million (Q2 2025), and $383.2 million (Q1 2025).